Entia Biosciences ERGO Stock
Entia Biosciences Price Chart
Entia Biosciences ERGO Financial and Trading Overview
Entia Biosciences stock price | 0.0001 USD |
Previous Close | 0.0002 USD |
Open | 0.0002 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0002 - 0.0002 USD |
52 Week Range | 0.0002 - 0.03 USD |
Volume | 12 USD |
Avg. Volume | 6 USD |
Market Cap | 235.63K USD |
Beta (5Y Monthly) | 12.075352 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ERGO Valuation Measures
Enterprise Value | 976.87K USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.88760144 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 3.68 |
Enterprise Value/EBITDA | -0.85 |
Trading Information
Entia Biosciences Stock Price History
Beta (5Y Monthly) | 12.075352 |
52-Week Change | -99.37% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.03 USD |
52 Week Low | 0.0002 USD |
50-Day Moving Average | 0.00022 USD |
200-Day Moving Average | 0.0004135 USD |
ERGO Share Statistics
Avg. Volume (3 month) | 6 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 33.66M |
Float | 22.64M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2016 |
Most Recent Quarter (mrq) | December 31, 2016 |
Next Fiscal Year End | December 31, 2017 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -439.74% |
Gross Margin | 65.53% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -164.37% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 265.47K USD |
Revenue Per Share (ttm) | 0.009 USD |
Quarterly Revenue Growth (yoy) | -32.80% |
Gross Profit (ttm) | 173.97K USD |
EBITDA | -1149682 USD |
Net Income Avi to Common (ttm) | -1395782 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 76.05K USD |
Total Cash Per Share (mrq) | 0.002 USD |
Total Debt (mrq) | 1.05M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.111 |
Book Value Per Share (mrq) | -0.07 |
Cash Flow Statement
Operating Cash Flow (ttm) | -715098 USD |
Levered Free Cash Flow (ttm) | -290649 USD |
Profile of Entia Biosciences
Country | United States |
State | OR |
City | Sherwood |
Address | 13565 SW Tualatin-Sherwood Road |
ZIP | 97140 |
Phone | 971-228-0709 |
Website | https://www.entiabio.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 6 |
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Q&A For Entia Biosciences Stock
What is a current ERGO stock price?
Entia Biosciences ERGO stock price today per share is 0.0001 USD.
How to purchase Entia Biosciences stock?
You can buy ERGO shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Entia Biosciences?
The stock symbol or ticker of Entia Biosciences is ERGO.
Which industry does the Entia Biosciences company belong to?
The Entia Biosciences industry is Biotechnology.
How many shares does Entia Biosciences have in circulation?
The max supply of Entia Biosciences shares is 2.36B.
What is Entia Biosciences Price to Earnings Ratio (PE Ratio)?
Entia Biosciences PE Ratio is now.
What was Entia Biosciences earnings per share over the trailing 12 months (TTM)?
Entia Biosciences EPS is 0 USD over the trailing 12 months.
Which sector does the Entia Biosciences company belong to?
The Entia Biosciences sector is Healthcare.